Chiron Real Estate Inc. — fact timeline

Chiron Real Estate Inc. issued 1,000,000 Series C Preferred Units of convertible note to Chiron Real Estate Inc. for proceeds received from the sale of the Series C Preferred Stock.

“The Company contributed the proceeds received from the sale of the Series C Preferred Stock to the Operating Partnership in exchange for the issuance of 1,000,000 Series C Preferred Units to the Company.”

Chiron Real Estate Inc. issued 1,000,000 shares of preferred stock to Maewyn XRN LP, Petrus Special Opportunities Fund, L.P., certain entities advised by Canyon Capital Advisors LLC and certain entities advised by Diameter Capital Partners LP for $100.00 per share for gross proceeds of approximately $100,000,000.

“On May 29, 2026 and June 2, 2026, the Company completed closings of its previously announced private placement (the “ Series C Private Placement ”), pursuant to which the Company issued an aggregate of 1,000,000 shares of Series C Preferred Stock for $100.00 per share for gross proceeds of approximately $100,000,000 to Maewyn XRN LP, Petrus Special Opportunities Fund, L.P., certain entities advised by Canyon Capital Advisors LLC and certain entities advised by Diameter Capital Partners LP (collectively, the “ Purchasers ”), pursuant to that certain Investment Agreement, dated as of May 6, 2026, by and among the Company and the purchasers party thereto (the “ Investment Agreement ”).”

Chiron Real Estate Inc.: Filed Articles Supplementary designating 1,000,000 shares of Series C Convertible Preferred Stock (effective 2026-05-28).

“On May 28, 2026, the Company filed Articles Supplementary with the Maryland State Department of Assessments and Taxation to designate 1,000,000 shares of the Company’s authorized preferred stock as shares of Series C Convertible Preferred Stock”

Chiron Real Estate Inc. completed an acquisition involving affiliates of Silverstone Senior Living for $118.9 million (closed 2026-06-01).

“On June 1, 2026, the Company, through one or more subsidiaries, closed on the acquisition of The Riviera Alexandria (the “ Riviera ”), a senior housing community located in Alexandria, Virginia for a purchase price of $118.9 million.”

Chiron Real Estate Inc. completed an acquisition involving affiliates of Silverstone Senior Living for $130 million (closed 2026-06-01).

“On June 1, 2026, the Company, through one or more subsidiaries, closed on the acquisition of The Landing Alexandria (the “ Landing ”), a senior housing community located in Alexandria, Virginia for a purchase price of $130 million.”

Chiron Real Estate Inc. incurred credit facility of $147 million with unknown at unknown maturing unknown.

“In connection with the closing of the acquisitions of the Landing and the Riviera, the Company, through the Operating Partnership, incurred approximately $147 million of additional indebtedness under the Company’s Third Amended and Restated Credit Facility (the “ Credit Facility ”).”

Chiron Real Estate Inc. entered into Seventh Amendment to the Agreement of Limited Partnership of Chiron Real Estate LP with Chiron Real Estate Inc. valued at Creates Series C Convertible Preferred Units with terms substantially similar to the 6.00% Series C (effective 2026-05-28).

“Item 1.01 Entry into a Material Definitive Agreement Seventh Amendment to the Agreement of Limited Partnership of Chiron Real Estate LP On May 28, 2026, Chiron Real Estate Inc. (the “ Company ”), as the sole member of the general partner of Chiron Real Estate LP (the “ Operating Partnership ”), entered into an amendment to the agreement of limited partnership of the Operating Partnership (the “ OP Amendment ”).”

Chiron Real Estate Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-05-20 meeting.

“Proposal 4 — Ratification of Appointment of Independent Registered Public Accounting Firm: For Against Abstain Broker Non-Votes 10,009,663 46,235 39,227 0”

Chiron Real Estate Inc. shareholders approved Amendment to the Company’s 2016 Equity Incentive Plan to (i) Extend the Term of the Plan through May 20, 2036 and (ii) Increase the Number of Shares Reserved For Issuance Thereunder by 300,000 Shares at the 2026-05-20 meeting.

“Proposal 3 — Amendment to the Company’s 2016 Equity Incentive Plan to (i) Extend the Term of the Plan through May 20, 2036 and (ii) Increase the Number of Shares Reserved For Issuance Thereunder by 300,000 Shares: For Against Abstain Broker Non-Votes 7,216,183 397,215 59,237 2,422,490”

Chiron Real Estate Inc. shareholders approved Election of Directors at the 2026-05-20 meeting.

“Proposal 1 — Election of Directors: Nominee for Director For Against Abstain Broker Non-Votes Jeffrey M. Busch 7,277,385 382,226 13,027 2,422,487 Matthew Cypher 7,540,152 101,738 30,752 2,422,483 Mark Decker, Jr. 7,431,868 210,788 29,984 2,422,485 Zhang Huiqi 6,793,234 844,930 34,471 2,422,490 Paula R. Crowley 7,536,881 102,357 33,400 2,422,487”

Chiron Real Estate Inc. shareholders approved Advisory Vote on Named Executive Officer Compensation at the 2026-05-20 meeting.

“Proposal 2 — Advisory Vote on Named Executive Officer Compensation: For Against Abstain Broker Non-Votes 7,144,118 394,460 134,058 2,422,489”

Charles Fitzgerald was appointed as Director at Chiron Real Estate Inc..

“On May 20, 2026, the Board of Directors (the “ Board ”) of Chiron Real Estate Inc. (the “ Company ”) approved an increase in the number of directors constituting the Board from six to seven directors and appointed Charles Fitzgerald to serve as a director of the Company, effective as of the same day, to serve until the Company’s 2027 Annual Meeting of Stockholders and until his successor is duly elected and qualified.”

Chiron Real Estate Inc. issued up to 1,000,000 shares of Series C Preferred Stock of preferred stock to Maewyn XRN LP and each other purchaser that may become a party to this Investment Agreement from time to time (collectively, the "Purchasers") for $100.00 per share, for aggregate gross proceeds of up to $100.0 million.

“the Company agreed to issue and sell to the Purchasers a total of 1,000,000 shares of a new series of 6.00% Series C Convertible Perpetual Preferred Stock, par value $0.001 per share (the “Series C Preferred Stock”), at a purchase price of $100.00 per share, for aggregate gross proceeds of up to $100.0 million (the “Commitment Amount”) (the “Private Placement”).”

Chiron Real Estate Inc. entered into Investor Rights Agreement with Purchasers (including Maewyn XRN LP and others) (effective 2026-05-06).

“In connection with the Private Placement, on May 6, 2026, the Company and the Purchasers entered an Investor Rights Agreement.”

Chiron Real Estate Inc. entered into Investment Agreement with Maewyn XRN LP and other purchasers valued at up to $100.0 million (effective 2026-05-06).

“On May 6, 2026, Chiron Real Estate Inc. (the “Company”) entered into an Investment Agreement (the “Investment Agreement”) with Maewyn XRN LP (the “Maewyn Purchaser”) and each other purchaser that may become a party to this Investment Agreement from time to time (collectively, the “Purchasers”). Pursuant to the Investment Agreement, the Company agreed to issue and sell to the Purchasers a total of 1,000,000 shares of a new series of 6.00% Series C Convertible Perpetual Preferred Stock, par value $0.001 per share (the “Series C Preferred Stock”), at a purchase price of $100.00 per share, for aggregate gross proceeds of up to $100.0 million (the “Commitment Amount”) (the “Private Placement”).”

Chiron Real Estate Inc. reported three months ended March 31, 2026 results: net income net loss attributable to common stockholders of $0.7 million, or $0.06 per diluted share.

“one-for-five reverse stock split that was effective September 19, 2025. First Quarter 2026 Highlights · Reported quarterly net loss attributable to common stockholders of $0.7 million, or $0.06 per diluted share, as compared to net income of $2.1 million, or $0.16 per diluted share, in the comparable prior year period. · Reported quarterly funds from”

Chiron Real Estate Inc. entered into Pinnacle Purchase Agreement with affiliates of Silverstone Senior Living valued at $173,055,000 (effective 2026-05-06).

“On May 6, 2026, the Company, through one or more subsidiaries, entered into an asset purchase agreement (the “Pinnacle Purchase Agreement” and together with the Landing Purchase Agreement and the Riviera Purchase Agreement, the “Purchase Agreements”) with an affiliate of Silverstone to acquire The Pinnacle North Bethesda (the “Pinnacle”), a senior housing community located in North Bethesda, Maryland, for an aggregate purchase price of $173,055,000, plus any applicable purchase price increase in connection with any closing extension, and subject to customary prorations and adjustments (including a purchase price adjustment based on the construction loan balance as of closing).”

Chiron Real Estate Inc. entered into Riviera Purchase Agreement with affiliates of Silverstone Senior Living valued at $118.9 million (effective 2026-05-01).

“On May 1, 2026, the Company, through one or more subsidiaries, entered into an agreement (the “Riviera Purchase Agreement”) with an affiliate of Silverstone to acquire The Riviera at Alexandria (the “Riviera”), a senior housing community located in Alexandria, Virginia, for an aggregate purchase price of $118.9 million, plus any applicable purchase price increase in connection with any closing extension, and subject to customary prorations and adjustments.”

Chiron Real Estate Inc. entered into Landing Purchase Agreement with affiliates of Silverstone Senior Living valued at $130.0 million (effective 2026-05-01).

“On May 1, 2026, Chiron Real Estate Inc. (the “Company”), through one or more subsidiaries, entered into a purchase and sale agreement (the “Landing Purchase Agreement”) with affiliates of Silverstone Senior Living (“Silverstone”) to acquire The Landing Alexandria (the “Landing”), a senior housing community located in Alexandria, Virginia, for a purchase price of $130.0 million, subject to customary prorations and adjustments.”

Chiron Real Estate Inc.: Filed Articles Supplementary to classify and designate additional 3,000,000 shares of Series B Preferred Stock, increasing total authorized Series B Preferred Stock to 5,300,000 shares (effective 2026-03-11).

“On March 11, 2026, the Company filed Articles Supplementary (the “Additional Series B Articles Supplementary”) to the Company’s charter with the State Department of Assessments and Taxation of the State of Maryland (the “SDAT”), to classify and designate 3,000,000 shares of the Company’s authorized but unissued preferred stock, par value $0.001 per share, as additional shares of Series B Preferred Stock, with the powers, preferences and privileges as set forth in the Articles Supplementary filed as Exhibit 3.3 to the Company’s Registration Statement on Form 8-A, filed with the U.S. Securities and Exchange Commission on November 18, 2025 (the “November 2025 Series B Articles Supplementary”).”

Chiron Real Estate Inc. amended Sixth Amendment to Agreement of Limited Partnership of Chiron Real Estate LP.

“In connection with the Preferred ATM Offering (as defined below) by Chiron Real Estate Inc. (the “Company”) of the Company’s 8.00% Series B Cumulative Redeemable Preferred Stock (the “Series B Preferred Stock”), the Agreement of Limited Partnership of Chiron Real Estate LP (the “Operating Partnership”) was amended (the “Amendment”) to provide for the issuance of up to an additional 3,000,000 of the Operating Partnership’s 8.00% Series B Cumulative Redeemable Preferred Units (liquidation preference $25.00 per unit) (the “Series B Preferred Units”).”

Chiron Real Estate Inc. entered into Master Note and Guaranty Agreement with NYL Investors LLC and certain affiliates valued at $150.0 million (effective 2026-03-02).

“On March 2, 2026, Chiron Real Estate LP (the “Operating Partnership”), as issuer, and Chiron Real Estate Inc., as a guarantor, entered into a Master Note and Guaranty Agreement (the “Agreement”) with NYL Investors LLC (“New York Life”) and certain affiliates of New York Life (collectively, the “Purchasers”).”

Chiron Real Estate Inc. incurred senior notes of up to $150.0 million with NYL Investors LLC and certain affiliates of New York Life maturing no more than ten years from the date of issuance.

“On March 2, 2026, Chiron Real Estate LP (the “Operating Partnership”), as issuer, and Chiron Real Estate Inc., as a guarantor, entered into a Master Note and Guaranty Agreement (the “Agreement”) with NYL Investors LLC (“New York Life”) and certain affiliates of New York Life (collectively, the “Purchasers”). The Agreement establishes an uncommitted senior note facility pursuant to which the Operating Partnership may, from time to time, issue senior unsecured promissory notes (the “Notes”) in one or more series to the Purchasers in an aggregate outstanding principal amount of up to $150.0 million.”

Chiron Real Estate Inc.: Changed company name from Global Medical REIT Inc. to Chiron Real Estate Inc (effective 2026-02-23).

“On February 19, 2026, the Company filed Articles of Amendment to its charter (the “Amendment”) with the Maryland State Department of Assessments and Taxation and amended and restated its Fourth Amended and Restated Bylaws (as so amended and restated, the “Fifth Amended and Restated Bylaws”), each effective as of 12:01 a.m., Eastern Time, on February 23, 2026, solely to change the Company’s name from Global Medical REIT Inc. to “Chiron Real Estate Inc.””

Chiron Real Estate Inc. issued 2,000,000 shares of its 8.00% Series B cumulative redeemable preferred stock of preferred stock to Raymond James & Associates, Inc., BMO Capital Markets Corp., Stifel, Nicolaus & Company, Incorporated and Robert W. Baird & Co. Incorporated for $25.00 per share.

“the Company filed Articles Supplementary with the Maryland State Department of Assessments and Taxation to designate 2,300,000 shares of the Company’s authorized preferred stock as shares of 8.00% Series B Cumulative Redeemable Preferred Stock, par value $0.001 per share, with a liquidation preference of $25.00 per share (“Series B Preferred Stock"), with the powers, preferences and privileges as set forth in the Articles Supplementary”

Chiron Real Estate Inc.: Filed Articles Supplementary to designate 2,300,000 shares of preferred stock as Series B Preferred Stock (effective 2025-11-18).

“On November 18, 2025, the Company filed Articles Supplementary with the Maryland State Department of Assessments and Taxation to designate 2,300,000 shares of the Company’s authorized preferred stock as shares of 8.00% Series B Cumulative Redeemable Preferred Stock, par value $0.001 per share, with a liquidation preference of $25.00 per share ("Series B Preferred Stock"), with the powers, preferences and privileges as set forth in the Articles Supplementary.”

Chiron Real Estate Inc.: One-for-five reverse stock split and reduction in authorized shares from 500,000,000 to 100,000,000 via Articles of Amendment to charter (effective 2025-09-19).

“The Amendment, effective as of 5:00 p.m. Eastern Time on September 19, 2025 (the “Effective Time”), converted every five shares of the issued and outstanding Common Stock into one share of common stock of the Company, par value $0.005 per share. The Reverse Stock Split also effected a proportionate reduction in the Company’s authorized shares of Common Stock from 500,000,000 shares to 100,000,000.”

Mark O. Decker, Jr. was appointed as Director at Chiron Real Estate Inc..

“the Board also increased the size of the Board from seven directors to eight directors and appointed Mr. Decker as a director effective June 23, 2025”

Mark O. Decker, Jr. was appointed as Chief Executive Officer and President at Chiron Real Estate Inc..

“Mark O. Decker, Jr, age 49, was appointed Chief Executive Officer and President of the Company, effective as of June 23, 2025.”

Jeffrey M. Busch was removed as non-executive Chairman at Chiron Real Estate Inc..

“Mr. Busch was removed from his position as Chief Executive Officer and President of the Company, effective June 23, 2025. Mr. Busch will continue to serve on the board of directors of the Company (the “Board”) as non-executive Chairman.”

Chiron Real Estate Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2024-05-15 meeting.

“Proposal 5 — Ratification of Appointment of Independent Registered Public Accounting Firm: For Against Abstain Broker Non-Votes 48,840,222 608,585 122,277 0”

Chiron Real Estate Inc. shareholders approved Amendment to the Company’s 2016 Equity Incentive Plan to Increase the Number of Shares Reserved for Issuance Thereunder by 1,500,000 Shares at the 2024-05-15 meeting.

“Proposal 4 — Amendment to the Company’s 2016 Equity Incentive Plan to Increase the Number of Shares Reserved for Issuance Thereunder by 1,500,000 Shares: For Against Abstain Broker Non-Votes 32,867,468 2,683,711 313,085 13,706,820”

Chiron Real Estate Inc. shareholders approved Advisory Vote on the Frequency of Future Advisory Votes on Named Executive Officer Compensation at the 2024-05-15 meeting.

“Proposal 3 — Advisory Vote on the Frequency of Future Advisory Votes on Named Executive Officer Compensation: 1 Year 2 Years 3 Years Abstain Broker Non-Votes 34,040,745 158,991 1,098,203 566,323 13,706,822”

Chiron Real Estate Inc. shareholders approved Advisory Vote on Named Executive Officer Compensation at the 2024-05-15 meeting.

“Proposal 2 — Advisory Vote on Named Executive Officer Compensation: For Against Abstain Broker Non-Votes 33,764,849 1,467,056 632,359 13,706,820”

Chiron Real Estate Inc. shareholders approved Election of Directors at the 2024-05-15 meeting.

“Proposal 1 — Election of Directors: Nominee for Director For Against Abstain Broker Non-Votes Jeffrey M. Busch 33,520,679 2,266,304 77,283 13,706,818 Matthew Cypher 34,365,340 1,417,356 81,570 13,706,818 Ronald Marston 34,271,830 1,506,912 85,523 13,706,819 Henry E. Cole 35,307,015 471,399 85,852 13,706,818 Zhang Huiqi 35,307,700 463,912 92,658 13,706,814 Paula R. Crowley 35,321,456 459,003 83,810 13,706,815 Lori Wittman 34,362,196 1,408,313 93,758 13,706,817”

Chiron Real Estate Inc. reported the three months ended March 31, 2024 results: revenue $35.1 million, net income $0.8 million, EPS $0.01 per diluted share.

“prior year period. · Portfolio leased occupancy was 96.4% at March 31, 2024. Financial Results Rental revenue for the first quarter 2024 decreased 3.0% year-over-year to $35.1 million, primarily reflecting the impact of the Company’s property dispositions that were completed during 2023. Total expenses for the first quarter were $32.8 million, compared to”

Chiron Real Estate Inc. reported year ended December 31, 2023 results: net income 14.8 million, EPS 0.23.

“Net income attributable to common stockholders was $14.8 million, or $0.23 per diluted share”

Chiron Real Estate Inc. reported three months ended December 31, 2023 results: revenue 33.0 million, net income -0.8 million, EPS -0.01.

“Total revenue decreased 9.2% year-over-year to $33.0 million”

Chiron Real Estate Inc. entered into Sales Agreement with BMO Capital Markets Corp., B. Riley Securities, Inc., Robert W. Baird & Co. Incorporated, Berenberg Capital Markets LLC, Colliers Securities LLC, Compass Point Research & Trading, LLC, Janney Montgomery Scott LLC, Citizens JMP Securities, LLC, J.P. Morgan Securities LLC, KeyBanc Capital Markets Inc. valued at $300,000,000 (effective 2024-01-09).

“On January 9, 2024, Global Medical REIT Inc. (the “ Company ”) and Global Medical REIT L.P., the Company’s operating partnership (the “ Operating Partnership ”), entered into a Sales Agreement (the “ Sales Agreement ”) with (i) BMO Capital Markets Corp., B. Riley Securities, Inc., Robert W. Baird & Co. Incorporated, Berenberg Capital Markets LLC, Colliers Securities LLC, Compass Point Research & Trading, LLC, Janney Montgomery Scott LLC, Citizens JMP Securities, LLC, J.P. Morgan Securities LLC, KeyBanc Capital Markets Inc., Samuel A. Ramirez & Company, Inc., Stifel, Nicolaus & Company, Incorporated, Truist Securities, Inc. and Wells Fargo Securities, LLC, as sales agents for the Company (the “ Agents ”), or principals (ii) BMO Capital Markets Corp., B. Riley Securities, Inc., Robert W. Baird & Co. Incorporated, Citizens JMP Securities, LLC, J.P. Morgan Securities LLC, KeyBanc Capital Markets Inc., Stifel, Nicolaus & Company, Incorporated, Truist Securities, Inc. and Wells Fargo Securit”

Chiron Real Estate Inc. reported three and nine months ended September 30, 2023 results: revenue total revenue increased slightly year-over-year to $35.5 million, net income Net income attributable to common stockholders was $3.1 million, or $0.05 per diluted share, EPS $0.05 per diluted share.

“or $0.23 per share and unit, as compared to $17.1 million, or $0.25 per share and unit, in the comparable prior year period. · Total revenue increased slightly year-over-year to $35.5 million, primarily driven by the Company’s acquisition activity during the comparable prior year period and the performance of its portfolio, partially offset by the impact of property”

Chiron Real Estate Inc. reported the six months ended June 30, 2023 results: revenue $72.6 million, net income $12.5 million, EPS $0.19 per diluted share.

“or $0.45 per share and unit, as compared to $34.4 million, or $0.49 per share and unit, in the comparable prior year period. · Increased total revenue 10.7% year-over-year to $72.6 million, primarily driven by the Company’s acquisition activity during and since the comparable prior year period and the performance of its portfolio. · Through June 30, 2023, inclusive”

Chiron Real Estate Inc. reported the three months ended June 30, 2023 results: revenue $36.4 million, net income $11.8 million, EPS $0.18 per diluted share.

“or $0.23 per share and unit, as compared to $17.6 million, or $0.25 per share and unit, in the comparable prior year period. · Increased total revenue 7.9% year-over-year to $36.4 million, primarily driven by the Company’s acquisition activity during and since the comparable prior year period and the performance of its portfolio. · In April 2023, completed the”

Chiron Real Estate Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2023-05-10 meeting.

“Proposal 3 — Ratification of Appointment of Independent Registered Public Accounting Firm: For Against Abstain Broker Non-Votes 49,809,327 101,966 111,774 0”

Chiron Real Estate Inc. shareholders approved Advisory Vote on Named Executive Officer Compensation at the 2023-05-10 meeting.

“Proposal 2 — Advisory Vote on Named Executive Officer Compensation: For Against Abstain Broker Non-Votes 33,561,467 1,309,381 693,840 14,458,379”

Chiron Real Estate Inc. shareholders approved Election of Directors at the 2023-05-10 meeting.

“Proposal 1 — Election of Directors: Nominee for Director For Against Abstain Broker Non-Votes Jeffrey M. Busch 33,499,263 1,976,607 88,818 14,458,379 Matthew Cypher 34,415,131 1,061,383 88,174 14,458,379 Ronald Marston 34,321,181 1,160,535 82,971 14,458,380 Henry E. Cole 35,067,940 403,187 93,562 14,458,378 Zhang Huiqi 35,069,774 396,332 98,583 14,458,378 Paula R. Crowley 35,123,526 347,118 94,047 14,458,376 Lori Wittman 34,398,440 1,073,516 92,733 14,458,378”

Chiron Real Estate Inc. reported the three months ended March 31, 2023 results: revenue $36.2 million, net income $0.7 million, EPS $0.01 per diluted share.

“or $0.23 per share and unit, as compared to $16.8 million, or $0.24 per share and unit, in the comparable prior year period. · Increased total revenue 13.7% year-over-year to $36.2 million, primarily driven by the Company’s acquisition activity since the comparable prior year period. · Sold a medical office building located in Jacksonville, Florida, receiving gross”

Chiron Real Estate Inc. reported the twelve months ended December 31, 2022 results: revenue $137.3 million, net income $13.3 million, EPS $0.20 per diluted share.

“or $0.98 per share and unit, as compared to $61.4 million, or $0.95 per share and unit, in the comparable prior year period. · Increased total revenue 18.4% year-over-year to $137.3 million, primarily driven by the Company’s acquisition activity since the comparable prior year period. · Completed 14 acquisitions encompassing an aggregate 583,253 leasable square”

Chiron Real Estate Inc. reported the three months ended December 31, 2022 results: revenue $36.3 million, net income $0.4 million, EPS $0.01 per diluted share.

“or $0.24 per share and unit, as compared to $16.4 million, or $0.24 per share and unit, in the comparable prior year period. · Increased total revenue 19.6% year-over-year to $36.3 million, primarily driven by the Company’s acquisition activity since the comparable prior year period. Full Year 2022 Highlights · Net income attributable to common stockholders was”

Dr. Roscoe Moore, Jr. departed as director at Chiron Real Estate Inc..

“On January 19, 2023, Dr. Roscoe Moore, Jr. notified the Board of Directors (the “Board”) of Global Medical REIT Inc. (the “Company”) that he intends to retire as a director of the Board, effective as of the Company’s 2023 Annual Meeting of Stockholders (the “Annual Meeting”).”

Chiron Real Estate Inc.: Board approved and adopted Fourth Amended and Restated Bylaws to ensure compliance with federal proxy rules, including Rule 14a-19, among other administrative amendments (effective 2022-12-07).

“Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. At a meeting of the Board of Directors (the “Board”) of Global Medical REIT Inc., a Maryland corporation (the “Company”), held on December 7, 2022, the Board approved and adopted effective as of such date the Fourth Amended and Restated Bylaws of the Company (the “Amended and Restated Bylaws”), amending certain provisions to ensure compliance with the federal proxy rules, including Rule 14a-19 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), among other administrative amendments.”